McNergney, Elyse – Trademark Portfolio

Entity Type: 01

McNergney, Elyse holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include IM = X. The owner is based in New York, NY.

210 West 101st St, Ste 14D

New York, NY 10025

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

IM = X
IM = X
Registered 1995
IMAX
IMAX
Cancelled 1994

Trademark Classifications

McNergney, Elyse's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does McNergney, Elyse have?

McNergney, Elyse has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.

What trademark classes does McNergney, Elyse file in?

McNergney, Elyse files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.

What are McNergney, Elyse's most well-known trademarks?

McNergney, Elyse's registered trademark portfolio includes well-known marks such as IM = X. These are among 1 currently registered trademark in the portfolio.

What is McNergney, Elyse's trademark registration success rate?

McNergney, Elyse has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.